Mangoceuticals, Ptb Ratio from 2010 to 2024

MGRX Stock   2.53  0.05  2.02%   
Mangoceuticals, Common PTB Ratio yearly trend continues to be fairly stable with very little volatility. PTB Ratio is likely to outpace its year average in 2024. PTB Ratio is price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on Mangoceuticals, Common's equity relative to its net asset value. View All Fundamentals
 
PTB Ratio  
First Reported
2010-12-31
Previous Quarter
7.64895554
Current Value
8.03
Quarterly Volatility
26 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mangoceuticals, Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mangoceuticals, Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.4 K, Interest Expense of 0.0 or Selling General Administrative of 6.8 M, as well as many indicators such as Price To Sales Ratio of 7.7, Dividend Yield of 0.0 or PTB Ratio of 8.03. Mangoceuticals, financial statements analysis is a perfect complement when working with Mangoceuticals, Common Valuation or Volatility modules.
  
Check out the analysis of Mangoceuticals, Common Correlation against competitors.

Latest Mangoceuticals, Common's Ptb Ratio Growth Pattern

Below is the plot of the Ptb Ratio of Mangoceuticals, Common Stock over the last few years. It is price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value. Mangoceuticals, Common's PTB Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mangoceuticals, Common's overall financial position and show how it may be relating to other accounts over time.
Ptb Ratio10 Years Trend
Slightly volatile
   Ptb Ratio   
       Timeline  

Mangoceuticals, Ptb Ratio Regression Statistics

Arithmetic Mean(49,594)
Geometric Mean14,761
Coefficient Of Variation(52.35)
Mean Deviation20,065
Median(62,135)
Standard Deviation25,965
Sample Variance674.2M
Range63.8K
R-Value0.69
Mean Square Error377.1M
R-Squared0.48
Significance0
Slope4,025
Total Sum of Squares9.4B

Mangoceuticals, Ptb Ratio History

2024 8.03
2023 7.65
2022 1691.94

About Mangoceuticals, Common Financial Statements

Mangoceuticals, Common investors use historical fundamental indicators, such as Mangoceuticals, Common's Ptb Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mangoceuticals, Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
PTB Ratio 7.65  8.03 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mangoceuticals, Stock Analysis

When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.